A newly formed Baltimore company has raised $110 million to commercialize a cancer-detecting blood test, developed by Johns Hopkins researchers, that doctors would give patients during routine physicals.
{iframe}https://www.baltimoresun.com/health/bs-bz-company-develops-hopkins-cancer-blood-test-20190529-story.html{/iframe}